Clinical Trial Update: MR-linac Guided Adaptive Radiotherapy for Inoperable Mediastinal Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial update on MR-linac guided adaptive radiotherapy for inoperable mediastinal tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mediastinal Tumor

Snippet

Sponsor: Sun Yat-sen University | Conditions: Mediastinal Tumor | Phase 2 | Status: UNKNOWN